AWA
MRNA icon

Aaron Wealth Advisors’s Moderna MRNA Stock Holding History

Aaron Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+2,959
New +$153K 0.01% 674
2022
Q2 		– Sell
-327
Closed -$56.3K – 591
2022
Q1 		$56.3K Buy
+327
New +$55.1K 0.01% 402

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Aaron Wealth Advisors's MRNA Position: Q2 2026 in Review

Aaron Wealth Advisors opened a new position in Moderna (MRNA) in Q2 2026: 2,959 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #674 among its holdings. This is a return to the name: Aaron Wealth Advisors previously reported a position in MRNA as recently as Q1 2022.

Aaron Wealth Advisors first reported a position in MRNA in Q1 2022 and has held it in 2 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Aaron Wealth Advisors held 2,959 shares of Moderna worth $207K as of Q2 2026.
  • Moderna was a new Aaron Wealth Advisors position in Q2 2026.
  • Moderna made up 0.01% of Aaron Wealth Advisors's portfolio in Q2 2026, its #674 holding.
  • Aaron Wealth Advisors first reported a position in Moderna in Q1 2022 and has held it in 2 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.